-
Something wrong with this record ?
6-Substituted purines as ROCK inhibitors with anti-metastatic activity
J. Voller, L. Zahajská, L. Plíhalová, J. Jeřábková, D. Burget, AC. Pataki, V. Kryštof, M. Zatloukal, J. Brábek, D. Rösel, V. Mik, M. Tkáč, T. Pospíšil, T. Gucký, K. Doležal, M. Strnad,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Protein Kinase Inhibitors chemical synthesis pharmacology MeSH
- rho-Associated Kinases antagonists & inhibitors MeSH
- Humans MeSH
- Molecular Structure MeSH
- Cell Line, Tumor MeSH
- Cell Movement drug effects MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents chemical synthesis pharmacology MeSH
- Purines chemical synthesis pharmacology MeSH
- Signal Transduction drug effects MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Rho-associated serine/threonine kinases (ROCKs) are principal regulators of the actin cytoskeleton that regulate the contractility, shape, motility, and invasion of cells. We explored the relationships between structure and anti-ROCK2 activity in a group of purine derivatives substituted at the C6 atom by piperidin-1-yl or azepan-1-yl groups. Structure-activity relationship (SAR) analyses suggested that anti-ROCK activity is retained, and may be further increased, by substitution of the parent compounds at the C2 atom or by expansion of the C6 side chain. These inhibitors of ROCK can reach effective concentrations within cells, as demonstrated by a decrease in phosphorylation of the ROCK target MLC, and by inhibition of the ROCK-dependent invasion of melanoma cells in the collagen matrix. Our study may be useful for further optimization of C6-substituted purine inhibitors of ROCKs and of other sensitive kinases identified by the screening of a broad panel of protein kinases.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028823
- 003
- CZ-PrNML
- 005
- 20220119145446.0
- 007
- ta
- 008
- 210105s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2019.103005 $2 doi
- 035 __
- $a (PubMed)31271944
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Voller, Jiří $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic; Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 3, 775 15 Olomouc, Czech Republic. Electronic address: jiri.voller@upol.cz.
- 245 10
- $a 6-Substituted purines as ROCK inhibitors with anti-metastatic activity / $c J. Voller, L. Zahajská, L. Plíhalová, J. Jeřábková, D. Burget, AC. Pataki, V. Kryštof, M. Zatloukal, J. Brábek, D. Rösel, V. Mik, M. Tkáč, T. Pospíšil, T. Gucký, K. Doležal, M. Strnad,
- 520 9_
- $a Rho-associated serine/threonine kinases (ROCKs) are principal regulators of the actin cytoskeleton that regulate the contractility, shape, motility, and invasion of cells. We explored the relationships between structure and anti-ROCK2 activity in a group of purine derivatives substituted at the C6 atom by piperidin-1-yl or azepan-1-yl groups. Structure-activity relationship (SAR) analyses suggested that anti-ROCK activity is retained, and may be further increased, by substitution of the parent compounds at the C2 atom or by expansion of the C6 side chain. These inhibitors of ROCK can reach effective concentrations within cells, as demonstrated by a decrease in phosphorylation of the ROCK target MLC, and by inhibition of the ROCK-dependent invasion of melanoma cells in the collagen matrix. Our study may be useful for further optimization of C6-substituted purine inhibitors of ROCKs and of other sensitive kinases identified by the screening of a broad panel of protein kinases.
- 650 _2
- $a protinádorové látky $x chemická syntéza $x farmakologie $7 D000970
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a pohyb buněk $x účinky léků $7 D002465
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a inhibitory proteinkinas $x chemická syntéza $x farmakologie $7 D047428
- 650 _2
- $a puriny $x chemická syntéza $x farmakologie $7 D011687
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a kinázy asociované s rho $x antagonisté a inhibitory $7 D054460
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zahajská, Lenka $u Isotope Laboratory, The Czech Academy of Sciences, Institute of Experimental Botany, Vídeňská 1083, 142 00 Prague 4, Czech Republic.
- 700 1_
- $a Plíhalová, Lucie $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic; Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Jeřábková, Jana $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Burget, David $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Pataki, Andreea Csilla $u Department of Cell Biology, Faculty of Science, Charles University in Prague, Viničná 7, 12843, Prague 2, Czech Republic.
- 700 1_
- $a Kryštof, Vladimír $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Zatloukal, Marek $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Brábek, Jan, $u Department of Cell Biology, Faculty of Science, Charles University in Prague, Viničná 7, 12843, Prague 2, Czech Republic. $d 1973- $7 xx0268678
- 700 1_
- $a Rösel, Daniel $u Department of Cell Biology, Faculty of Science, Charles University in Prague, Viničná 7, 12843, Prague 2, Czech Republic.
- 700 1_
- $a Mik, Václav $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Tkáč, Martin $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Pospíšil, Tomáš $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Gucký, Tomáš, $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic. $d 1978- $7 ola2005284374
- 700 1_
- $a Doležal, Karel $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic; Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 700 1_
- $a Strnad, Miroslav $u Laboratory of Growth Regulators, The Czech Academy of Sciences, Institute of Experimental Botany & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic.
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 90, č. - (2019), s. 103005
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31271944 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20220119145443 $b ABA008
- 999 __
- $a ok $b bmc $g 1609158 $s 1120003
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 90 $c - $d 103005 $e 20190606 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20210105